Navigation Links
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
Date:5/14/2013

PARIS and TARRYTOWN, N.Y., May 15, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the COMPARE and ASCERTAIN trials of sarilumab, the first fully human monoclonal antibody directed against the IL-6 receptor, which is delivered by subcutaneous injection every other week, have enrolled their first patients.

The broad SARIL-RA clinical development program is focused on adult populations with moderate-to-severe rheumatoid arthritis (RA) who are inadequate responders to either methotrexate (MTX) or tumor necrosis factor alpha (TNF-alpha) inhibitor therapy.  The SARIL-RA program is comprised of the following five trials: SARIL-RA MOBILITY, SARIL-RA TARGET, SARIL-RA COMPARE, SARIL-RA ASCERTAIN, and an open-label extension trial, SARIL-RA EXTEND.  The program is targeted to enroll approximately 2,600 patients with moderate-to-severe rheumatoid arthritis.  The primary objective of the overall Phase 3 program is to determine the safety and efficacy of sarilumab in reducing the signs and symptoms of RA, as well as inhibiting disease progression, in a broad range of patients.  Two doses of sarilumab are being studied in the SARIL-RA program: 150 milligrams (mg) every other week and 200mg every other week. 

The SARIL-RA ASCERTAIN trial is a multi-center, randomized, double-blind, active-calibrator, Phase 3 trial of 24 weeks that will assess the safety and tolerability of sarilumab and tocilizumab, both in combination with MTX, in patients with RA who are inadequate responders to, or intolerant of, TNF-alpha inhibitors.  The primary endpoint of this study is safety.

"Despite the advances that TNF-alpha inhibitors have made in the management of patients with RA, up to 40 percent of patients are inadequately c
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
2. NextBio Announces Translational Medicine Partnership with Sanofi
3. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
4. Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness
5. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
6. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
7. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
8. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
9. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
10. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
11. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... BURLINGTON, N.C. , April 21, ... DGX ), the world,s leading provider of diagnostic ... of Health and Medical Research institution, today launched ... to provide scientists and laboratory organizations around the ... genetic data. The program,s goal is to accelerate ...
(Date:4/21/2015)... Mindray Medical International Limited ("Mindray", NYSE: MR ), ... worldwide, today announced that it will report its financial ... after the U.S. market closes on May 11, 2015. ... 8:00 AM on May 12, 2015 U.S. Eastern Time ... Dial-in details for the earnings conference ...
(Date:4/21/2015)... ANGELES , April 21, 2015  Legal-Bay ... that Pradaxa,s maker, Boehringer Ingelheim Pharmaceuticals, is seeking ... DVT and PE. According to PBR, Boehringer submitted ... FDA in hopes that Pradaxa will be approved ... and pulmonary embolism (PE) for patients who have ...
Breaking Medicine Technology:Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 3Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 4Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 5Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 6Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 7Mindray to Report 2015 First Quarter Financial Results on May 11, 2015 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3
... , FRANKLIN LAKES, N.J. , Jan. 15 ... of its affiliate companies and the Medco Foundation, today announced the ... assist in the global humanitarian relief effort for victims of the ... quickly reach those in need, Medco is partnering with AmeriCares, a ...
... Jan. 15 The United States has filed ... & Johnson (J&J) of New Brunswick, N.J. , and ... Johnson Health Care Systems Inc., the Justice Department announced today.  ... in kickbacks to Omnicare Inc., the nation,s largest pharmacy that ...
Cached Medicine Technology:Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake 2Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake 3Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake 4U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nation's Largest Nursing Home Pharmacy 2U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nation's Largest Nursing Home Pharmacy 3
(Date:4/21/2015)... The PracticeMatch Career Fair will take ... at the William and Ida Friday Center at UNC-Chapel Hill, ... 50 hospitals, clinics and groups with career opportunities will be ... Attendees will enjoy free hors d’oeuvres and raffle prize drawings. ... says “Chapel Hill is an ideal location to hold ...
(Date:4/21/2015)... April 21, 2015 Nashville, Tenn. ... and provider of Picture Archiving and Communication Systems ... four new installations in the first quarter of ... Pinnacle Orthopaedics (McMinnville, TN) and Lowcountry Orthopaedics & ... viewer and data archiving services. Mt. San Rafael ...
(Date:4/21/2015)... WA (PRWEB) April 21, 2015 One ... dieting is still between meal food cravings. Many diets ... food cravings experienced between meals. Some attempt to eat ... to be eaten at more regular intervals. While this ... with food cravings, even directly after a meal. For ...
(Date:4/21/2015)... The University of Scranton has ... Informatics to answer the growing demand for professionals ... comprehensive wellness profile for better individual, real-world care. ... and implementation of health services and systems. This ... managerial operations in the healthcare sector,” says Margarete ...
(Date:4/21/2015)... 21, 2015 As nationally recognized ... in various components of breast reconstruction research spanning ... , "Breast reconstruction research continues to significantly contribute ... recent advances, many unanswered questions remain requiring continuous ... optimal results," says Dr. Oscar Ochoa emphasizing the ...
Breaking Medicine News(10 mins):Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 3Health News:Radsource Adds 4 ProtonPACS Clients in 1st Quarter 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 3Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5
... Business School,s Social Enterprise Program What: The Social ... Forum that features speakers and discussants with an insider,s perspective ... New York. When: ,Thursday, April 28, 2011, 8:00 a.m. ... University, 64 Morningside Drive (Entrance off 116th Street, East of ...
... , FRIDAY, April 22 (HealthDay News) -- Women who ... to have children with behavioral problems, a new study ... Telethon Institute for Child Health Research in Perth, Australia, ... had shown a link between stress during pregnancy and ...
... 22, 2011 One of the world,s foremost glaucoma researchers, ... Farfel Award, the highest distinction bestowed upon faculty by the ... of $10,000, the Farfel Award is a symbol of overall ... is the 33rd recipient. "I feel very honored ...
... , FRIDAY, April 22 (HealthDay News) -- New ... symptoms of irritable bowel syndrome. Researchers from the ... an "anti-pain" channel in the colon. This contributes to ... "Our research shows that peppermint acts through ...
... -- (Bronx, NY) -- Transplanting cells from healthy adult livers ... millions of people worldwide, according to an animal study in ... Clinical Investigation . Jayanta Roy-Chowdhury, M.D. , professor ... Albert Einstein College of Medicine of Yeshiva University, ...
... An article in Science Signaling by researchers ... (RCAI) has clarified for the first time the mechanism ... The finding establishes a role for the extracellular signal-regulated ... key step toward the development of B cell-targeted drugs ...
Cached Medicine News:Health News:Columbia Business School hosts American Healthcare Landscape in 2014 Leadership Forum 2Health News:Pregnant and Stressed May Mean Offspring Who Misbehave 2Health News:Renowned glaucoma researcher receives University of Houston’s highest honor 2Health News:Liver-cell transplants show promise in reversing genetic disease affecting liver and lungs 2Health News:Signaling pathway reveals mechanism for B cell differentiation in immune response 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: